290 related articles for article (PubMed ID: 28895440)
1. Unravelling the biology of chromatin in health and cancer using proteomic approaches.
Eubanks CG; Dayebgadoh G; Liu X; Washburn MP
Expert Rev Proteomics; 2017 Oct; 14(10):905-915. PubMed ID: 28895440
[TBL] [Abstract][Full Text] [Related]
2. The contribution of mass spectrometry-based proteomics to understanding epigenetics.
Noberini R; Sigismondo G; Bonaldi T
Epigenomics; 2016 Mar; 8(3):429-45. PubMed ID: 26606673
[TBL] [Abstract][Full Text] [Related]
3. Proteomic approaches for cancer epigenetics research.
Marchione DM; Garcia BA; Wojcik J
Expert Rev Proteomics; 2019 Jan; 16(1):33-47. PubMed ID: 30482069
[No Abstract] [Full Text] [Related]
4. Proteomics in chromatin biology and epigenetics: Elucidation of post-translational modifications of histone proteins by mass spectrometry.
Sidoli S; Cheng L; Jensen ON
J Proteomics; 2012 Jun; 75(12):3419-33. PubMed ID: 22234360
[TBL] [Abstract][Full Text] [Related]
5. Proteomics in epigenetics: new perspectives for cancer research.
Bartke T; Borgel J; DiMaggio PA
Brief Funct Genomics; 2013 May; 12(3):205-18. PubMed ID: 23401080
[TBL] [Abstract][Full Text] [Related]
6. Middle-down proteomics: a still unexploited resource for chromatin biology.
Sidoli S; Garcia BA
Expert Rev Proteomics; 2017 Jul; 14(7):617-626. PubMed ID: 28649883
[TBL] [Abstract][Full Text] [Related]
7. Biochemical systems approaches for the analysis of histone modification readout.
Soldi M; Bremang M; Bonaldi T
Biochim Biophys Acta; 2014 Aug; 1839(8):657-68. PubMed ID: 24681439
[TBL] [Abstract][Full Text] [Related]
8. Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigations.
Önder Ö; Sidoli S; Carroll M; Garcia BA
Expert Rev Proteomics; 2015; 12(5):499-517. PubMed ID: 26400466
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometry-based proteomics: from cancer biology to protein biomarkers, drug targets, and clinical applications.
Jimenez CR; Verheul HM
Am Soc Clin Oncol Educ Book; 2014; ():e504-10. PubMed ID: 24857147
[TBL] [Abstract][Full Text] [Related]
10. Analyzing chromatin remodeling complexes using shotgun proteomics and normalized spectral abundance factors.
Florens L; Carozza MJ; Swanson SK; Fournier M; Coleman MK; Workman JL; Washburn MP
Methods; 2006 Dec; 40(4):303-11. PubMed ID: 17101441
[TBL] [Abstract][Full Text] [Related]
11. Of proteins and DNA--proteomic role in the field of chromatin research.
Lambert JP; Baetz K; Figeys D
Mol Biosyst; 2010 Jan; 6(1):30-7. PubMed ID: 20024064
[TBL] [Abstract][Full Text] [Related]
12. Clinical proteomics in cancer: Where we are.
Panis C; Pizzatti L; Souza GF; Abdelhay E
Cancer Lett; 2016 Nov; 382(2):231-239. PubMed ID: 27561426
[TBL] [Abstract][Full Text] [Related]
13. Harnessing the power of proteomics for identification of oncogenic, druggable signalling pathways in cancer.
Murray HC; Dun MD; Verrills NM
Expert Opin Drug Discov; 2017 May; 12(5):431-447. PubMed ID: 28286965
[TBL] [Abstract][Full Text] [Related]
14. Towards cracking the epigenetic code using a combination of high-throughput epigenomics and quantitative mass spectrometry-based proteomics.
Stunnenberg HG; Vermeulen M
Bioessays; 2011 Jul; 33(7):547-51. PubMed ID: 21607996
[TBL] [Abstract][Full Text] [Related]
15. Purification of specific chromatin loci for proteomic analysis.
Byrum SD; Taverna SD; Tackett AJ
Methods Mol Biol; 2015; 1228():83-92. PubMed ID: 25311124
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.
Huang R; Chen Z; He L; He N; Xi Z; Li Z; Deng Y; Zeng X
Theranostics; 2017; 7(14):3559-3572. PubMed ID: 28912895
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Approaches for Biomarker Panels in Cancer.
Tanase C; Albulescu R; Neagu M
J Immunoassay Immunochem; 2016; 37(1):1-15. PubMed ID: 26565430
[TBL] [Abstract][Full Text] [Related]
18. Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.
Vermeulen M; Eberl HC; Matarese F; Marks H; Denissov S; Butter F; Lee KK; Olsen JV; Hyman AA; Stunnenberg HG; Mann M
Cell; 2010 Sep; 142(6):967-80. PubMed ID: 20850016
[TBL] [Abstract][Full Text] [Related]
19. Recent Achievements in Characterizing the Histone Code and Approaches to Integrating Epigenomics and Systems Biology.
Janssen KA; Sidoli S; Garcia BA
Methods Enzymol; 2017; 586():359-378. PubMed ID: 28137571
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry-based proteomics in cancer research.
Cho WC
Expert Rev Proteomics; 2017 Sep; 14(9):725-727. PubMed ID: 28783987
[No Abstract] [Full Text] [Related]
[Next] [New Search]
